Scientists in China Successfully Reverse Type 1 and Type 2 Diabetes in Humans

In a major medical breakthrough, researchers in China have successfully used stem cell therapy to reverse both type 1 and type 2 diabetes in human patients.

The treatment restores the body’s natural ability to produce insulin, moving beyond lifelong symptom management and pointing toward a future where diabetes may no longer be permanent.

How Researchers Reversed Type 2 Diabetes

Chinese researchers used advanced stem cell technology to create insulin-producing pancreatic cells in the laboratory. These lab-grown cells were then transplanted into a patient with type 2 diabetes.

After receiving the treatment, the patient no longer required insulin injections or diabetes medications to control blood sugar levels.

Stem cells are often described as the body’s “blank slate” cells. They have the ability to transform into many different types of cells, including heart or pancreatic cells, and can repair or replace damaged tissue.

In this case, scientists guided stem cells in the lab to become pancreatic islet cells, the cells responsible for producing insulin. Once transplanted into the patient, the engineered cells functioned like healthy pancreatic cells. As a result, the patient’s body was able to regulate blood sugar naturally, eliminating the need for external insulin.

How This Differs From Traditional Diabetes Treatment

Conventional diabetes care focuses on controlling symptoms. Treatment typically includes:

• Diet and exercise to manage blood sugar
• Medications that help the body use insulin more effectively
• Insulin injections when the pancreas does not produce enough

These approaches are effective at keeping blood glucose within a safe range. However, they do not address the underlying problem, either the loss of functional insulin-producing cells or the body’s inability to properly use insulin.

Stem cell therapy aims to replace or restore the damaged cells themselves, targeting the root cause of the disease instead of simply managing it.

Previous Success in Type 1 Diabetes

China has also reported success in treating type 1 diabetes with stem cell therapy.

In a previous case, a young patient with type 1 diabetes began producing her own insulin after years of injections. Researchers reprogrammed the patient’s own fat-derived cells into insulin-producing islet cells and implanted them into her abdomen. She remained free of insulin injections for more than a year after the procedure.

Although type 1 and type 2 diabetes are different conditions, success in both cases highlights the growing potential of stem cell therapies to transform diabetes care.

What This Means for Millions of Patients

More than 580 million people worldwide live with diabetes. If these findings are confirmed through larger clinical trials, this approach could significantly reduce the daily burden of managing the disease and lower the risk of long-term complications such as heart disease, kidney failure, and nerve damage.

However, experts caution that a single case does not represent a universal cure. Larger and more comprehensive clinical trials are still needed to confirm the treatment’s safety, long-term effectiveness, and durability before it can be widely used.